asparagine has been researched along with Carcinoma, Ductal, Pancreatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Li, G; Lu, Y; Wang, Z; Yang, S | 1 |
| Aguera, K; Dufour, E; Gay, F; Godfrin, Y; Horand, F; Lorenzi, PL; Scoazec, JY | 1 |
| Abbruzzese, JL; Bondy, ML; Evans, DB; Hassan, MM; Jiao, L; Li, D | 1 |
3 other study(ies) available for asparagine and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
The edited UPF1 is correlated with elevated asparagine synthetase in pancreatic ductal adenocarcinomas.
Topics: Asparagine; Aspartate-Ammonia Ligase; beta-Globins; Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor; Carcinoma, Pancreatic Ductal; Carrier Proteins; Humans; Mutagenesis, Site-Directed; Pancreatic Neoplasms; RNA Helicases; RNA, Messenger; Trans-Activators | 2022 |
Pancreatic tumor sensitivity to plasma L-asparagine starvation.
Topics: Animals; Antineoplastic Agents; Asparaginase; Asparagine; Aspartate-Ammonia Ligase; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Erythrocytes; Humans; Immunohistochemistry; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.
Topics: Adenocarcinoma; Aged; Amino Acid Substitution; Asparagine; Aspartic Acid; Carcinoma, Pancreatic Ductal; Case-Control Studies; Female; Gene Frequency; Genotype; Glutamine; Haplotypes; Humans; Linkage Disequilibrium; Lysine; Male; Middle Aged; Pancreatic Neoplasms; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Xeroderma Pigmentosum Group D Protein | 2007 |